Celia Chao

Celia Chao

Auto-generated profile, based on publicly available information

Celia Chao

Human Pathophysiology and Translational Medicine Graduate Program, Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2017 in Cancer Research
Verified
Journal Article
Closed access
PDF file
CPChes'NIque M. Phillips
Ches'NIque M. Phillips
JZJohn R. Zatarain
John R. Zatarain
MNMichael E. Nicholls
Michael E. Nicholls
CPCraig Porter
Craig Porter
SWSteve G. Widen
Steve G. Widen
MHMark Richard Hellmich
Mark Richard Hellmich
The trans-sulfuration enzyme cystathionine-β-synthase (CBS) and its product hydrogen sulfide (H2S) are aberrantly upregulated in colorectal cancers, where they contribute to tumor growth and progression by both autocrine and paracrine mechanisms. However, it is unknown whether the CBS/H2S axis plays a role in colorectal carcinogenesis. Here, we report upregulation of CBS in human biopsies of precancerous adenomatous polyps and show that forced upregulation of CBS in an adenoma-like colonic epithelial cell line is sufficient to induce metabolic and gene expression profiles characteristic of colorectal cancer cells. Differentially expressed metabolites (65 increased and 20 decreased) clustered into the glycolytic pathway, nucleotide sugars, intermediates of the pentose phosphate pathway, and lipogenesis, including primarily phospholipids, sphingolipids, and bile acids. CBS upregulation induced broad changes in the NCM356 cell transcriptome with over 350 differentially expressed genes. These genes overlapped significantly with gene sets related to glycolysis, hypoxia, and a colon cancer cell phenotype, including genes regulated by NF-κB, KRAS, p53, and Wnt signaling, genes downregulated after E-cadherin knockdown, and genes related to increased extracellular matrix, cell adhesion, and epithelial-to-mesenchymal transition. The CBS-induced switch to an anabolic metabolism was associated with increased NCM356 cell bioenergetics, proliferation, invasion through Matrigel, resistance to anoikis, and CBS-dependent tumorigenesis in immunocompromised mice. Genetic ablation of CBS in CBS heterozygous mice (CBS+/−) reduced the number of mutagen-induced aberrant colonic crypt foci. Taken together, these results establish that activation of the CBS/H2S axis promotes colon carcinogenesis. Cancer Res; 77(21); 5741–54. ©2017 AACR.

1 December 2003 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CCCelia Chao
Celia Chao
JSJamie L. Studts
Jamie L. Studts
TATroy Abell
Troy Abell
THTerence Hadley
Terence Hadley
LRLynne Roetzer
Lynne Roetzer
KMKelly M. McMasters
Kelly M. McMasters
Purpose: The purpose of this study was to examine the impact of four methods of communicating survival benefits on chemotherapy decisions. We hypothesized that the four methods of communicating mathematically equivalent risk information would lead to different chemotherapy decisions. Methods: Each participant received two hypothetical scenarios regarding their mother (a postmenopausal woman with an invasive, lymph node-negative, hormone receptor-positive breast cancer) and was asked to decide whether they would encourage their mother to take chemotherapy in addition to surgery and tamoxifen. In the part 1, participants received one of four methods of describing the chemotherapy survival benefit: (1) relative risk reduction, (2) absolute risk reduction, (3) absolute survival benefit, or (4) number needed to treat. In part 2, each participant received all four methods. Following each decision, participants were asked to rate their confidence and confusion regarding their decision. Results: Participants included 203 preclinical medical students. In part 1, participants who received relative risk reduction information were significantly more likely to endorse chemotherapy. In part 2, there were no treatment decision differences when participants received all four methods of communicating survival benefits of chemotherapy. However, receiving all four methods led to significantly higher ratings of confusion. In deciding on endorsing chemotherapy, participants understood the information best when presented with data in the absolute survival benefit format. Conclusion: These results support the hypothesis that the method used to present information about chemotherapy influences treatment decisions. Absolute survival benefit is the most easily understood method of conveying the information regarding benefit of treatment.

1 March 2012 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
CCCelia Chao
Celia Chao
JCJ Russ Carmical
J Russ Carmical
KIKirk L Ives
Kirk L Ives
TWThomas G Wood
Thomas G Wood
JAJudith F Aronson
Judith F Aronson
MHMark R Hellmich
Mark R Hellmich

1 June 2015 in Journal of Surgical Research
Verified
Journal Article
Closed access
AMAmy A. Mrazek
Amy A. Mrazek
LPLaura J. Porro
Laura J. Porro
VBVandanajay Bhatia
Vandanajay Bhatia
MFMiriam Falzon
Miriam Falzon
HSHeidi Spratt
Heidi Spratt
MHMark R. Hellmich
Mark R. Hellmich

1 October 2014 in Surgical Clinics of North America
Verified
Journal Article
Closed access
AMAmy A. Mrazek
Amy A. Mrazek
CCCelia Chao
Celia Chao

5 July 2017 in Anticancer Research
Verified
Journal Article
Open access
PDF file
CCCelia Chao
Celia Chao
SWSteve G. Widen
Steve G. Widen
TWThomas G. Wood
Thomas G. Wood
JZJohn R. Zatarain
John R. Zatarain
PJPaul Johnson
Paul Johnson
MHMark R. Hellmich
Mark R. Hellmich
Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is the preferred experimental model to study tumor response to therapeutic agents. Gradually, human stromal cells are replaced by mouse stromal cells; however, the exact timing of the replacement of human with murine stromal cells in human CRC xenograft has not been fully elucidated. We hypothesize that orthologous murine transcripts functionally substitutes for the loss due to replacement of human stromal genes. Materials and Methods: Human CRC were implanted in athymic nude mice in replicates and followed-up over time. Using next-generation sequencing, we determined the temporal kinetics of human stromal cell replacement with the orthologous murine transcripts. Results: CRC cell-induced re-organization of the normal, quiescent murine stromal cells into a protumorigenic phenotype supporting human CRC growth occurs at initial implantation. Conclusion: Murine cell replacement occurs in a time- and size-dependent manner.